Drug-Induced Subacute Cutaneous Lupus Erythematosus: Identifying Patients at Risk for Systemic Lupus Erythematosus

Journal of the American Academy of Dermatology·September 16

Dermatology Drug-Induced Lupus Subacute Cutaneous Lupus Erythematosus Systemic Lupus Erythematosus

Summary

What was studied

Which patients with drug-induced subacute cutaneous lupus erythematosus (DI-SCLE) are at elevated risk of developing systemic lupus erythematosus (SLE).

Caveats

No abstract or full text was provided for this paper — only title and metadata. All extracted fields are based solely on the title; key results, sample size, study design, and limitations could not be determined

Drug-Induced Subacute Cutaneous Lupus Erythematosus: Identifying Patients at Risk for Systemic Lupus Erythematosus

Summary

What was studied

Caveats

Related Questions

Drug-Induced Subacute Cutaneous Lupus Erythematosus: Identifying Patients at Risk for Systemic Lupus Erythematosus

Summary

What was studied

Caveats

Related Questions